BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15470440)

  • 1. Growing pains in AIDS drug development.
    Herrera S
    Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440
    [No Abstract]   [Full Text] [Related]  

  • 2. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 3. Designing drugs against heterogeneous targets.
    Freire E
    Nat Biotechnol; 2002 Jan; 20(1):15-6. PubMed ID: 11753347
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacia pilots patent share for HIV drug.
    Nat Rev Drug Discov; 2003 Apr; 2(4):254. PubMed ID: 12680360
    [No Abstract]   [Full Text] [Related]  

  • 6. The ultimate model organism: progress in experimental medicine.
    Littman BH; Williams SA
    Nat Rev Drug Discov; 2005 Aug; 4(8):631-8. PubMed ID: 16056389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
    Elliott C
    New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
    [No Abstract]   [Full Text] [Related]  

  • 8. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 9. The fine line between education and marketing.
    Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In biomarkers we trust?
    Baker M
    Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
    [No Abstract]   [Full Text] [Related]  

  • 11. Carlo Incerti.
    Incerti C
    Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428
    [No Abstract]   [Full Text] [Related]  

  • 12. The time is now.
    Nat Rev Drug Discov; 2005 Aug; 4(8):613. PubMed ID: 16106580
    [No Abstract]   [Full Text] [Related]  

  • 13. Generic drugs allowed in global trial of AIDS therapy.
    Check E
    Nature; 2004 Oct; 431(7012):1028. PubMed ID: 15510113
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial drug discovery: is small pharma the solution?
    Boggs AF; Miller GH
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS. Still no vaccine, but better antiviral drugs are on the way.
    Park A
    Time; 2001 Jan; 157(2):70-2. PubMed ID: 11195691
    [No Abstract]   [Full Text] [Related]  

  • 17. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS and the next 25 years.
    Bernstein A
    Science; 2008 May; 320(5877):717. PubMed ID: 18467559
    [No Abstract]   [Full Text] [Related]  

  • 19. US to limit AIDS trials in developing nations.
    Ready T
    Nat Med; 2003 Jun; 9(6):629. PubMed ID: 12778141
    [No Abstract]   [Full Text] [Related]  

  • 20. Panel backs AIDS drugs.
    AIDS Read; 2007 Nov; 17(11):528. PubMed ID: 18069147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.